EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil

BACKGROUND: Targeted and immunotherapies are currently moving toward early-stage settings for patients with non-small cell lung cancer (NSCLC). Predictive biomarkers data are scarce in this scenario. We aimed to describe the frequency of EGFR mutations and PD-L1 expression levels in early-stage non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves Pinto, Icaro, de Oliveira Cavagna, Rodrigo, Virginio da Silva, Aline Larissa, Dias, Josiane Mourão, Santana, Iara Vidigal, Souza, Laísa Caroline, Ferreira da Silva, Flávio Augusto, Biazotto Fernandes, Maria Fernanda, Junqueira Pinto, Gustavo Dix, Negreiros, Izabella Santos, Santiago Gonçalves, Maria Fernanda, de Paula, Flávia Escremim, Berardinelli, Gustavo Nóriz, Casagrande, Giovanna Maria Stanfoca, Oliveira da Silva, Marcela, Albino da Silva, Eduardo Caetano, de Oliveira, Marco Antonio, Jacinto, Alexandre Arthur, Duval da Silva, Vinicius, Reis, Rui Manuel, De Marchi, Pedro, Leal, Letícia Ferro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Global Health and Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632322/
https://www.ncbi.nlm.nih.gov/pubmed/36099421
http://dx.doi.org/10.1093/oncolo/oyac167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632322/
https://www.ncbi.nlm.nih.gov/pubmed/36099421
http://dx.doi.org/10.1093/oncolo/oyac167

Ejemplares similares